Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 105

1.

Insights into the labeling effect of Kidney Donor Performance Index reporting: The Australian experience.

Sypek MP, Hughes P, Holdsworth R, Kanellis J, McDonald S, Clayton PD.

Am J Transplant. 2019 Oct 12. doi: 10.1111/ajt.15656. [Epub ahead of print]

PMID:
31605565
2.

The experiences and impact of being deemed ineligible for living kidney donation: Semi-structured interview study.

Ralph AF, Chadban SJ, Butow P, Craig JC, Kanellis J, Wong G, Logeman C, Tong A.

Nephrology (Carlton). 2019 Jul 1. doi: 10.1111/nep.13628. [Epub ahead of print]

PMID:
31257667
3.

Recurrent membranoproliferative glomerulonephritis in a renal transplant secondary to monoclonal gammopathy of renal significance successfully treated with bortezomib.

Chow KL, Kanellis J, Dayan S, Ryan J.

Intern Med J. 2019 Jun;49(6):801-802. doi: 10.1111/imj.14313. No abstract available.

PMID:
31185533
4.

External validation of the US and UK kidney donor risk indices for deceased donor kidney transplant survival in the Australian and New Zealand population.

Clayton PA, Dansie K, Sypek MP, White S, Chadban S, Kanellis J, Hughes P, Gulyani A, McDonald S.

Nephrol Dial Transplant. 2019 Dec 1;34(12):2127-2131. doi: 10.1093/ndt/gfz090.

PMID:
31157885
5.

Frequency and outcomes of kidney donation from intensive care patients with acute renal failure requiring renal replacement therapy.

Sanders JM, Opdam HI, Furniss H, Hughes PD, Kanellis J, Jones D.

Nephrology (Carlton). 2019 Dec;24(12):1296-1303. doi: 10.1111/nep.13601. Epub 2019 Jun 10.

PMID:
31081209
6.

KHA-CARI commentary on the KDIGO clinical practice guideline on the evaluation and care of living kidney donors.

Boudville N, Kanellis J.

Nephrology (Carlton). 2020 Jan;25(1):96-98. doi: 10.1111/nep.13602. Epub 2019 May 13. No abstract available.

PMID:
31081203
7.

A simple score can identify kidney transplant recipients at high risk of severe infection over the following 2 years.

Dendle C, Polkinghorne KR, Mulley WR, Gan PY, Kanellis J, Stuart RL, Thursky K, Holdsworth SR.

Transpl Infect Dis. 2019 Jun;21(3):e13076. doi: 10.1111/tid.13076. Epub 2019 Apr 22.

PMID:
30875147
8.

Risk Indices in Deceased-donor Organ Allocation for Transplantation: Review From an Australian Perspective.

Ling JEH, Fink M, Westall G, Macdonald P, Clayton PA, Holdsworth R, Opdam H, Polkinghorne KR, Kanellis J.

Transplantation. 2019 May;103(5):875-889. doi: 10.1097/TP.0000000000002613. Review.

PMID:
30801513
9.

Measurement of Humoral Immune Competence and the Risk of Sinopulmonary Infection in a Cohort of Kidney Transplant Recipients.

Dendle C, Stuart RL, Mulley WR, Polkinghorne KR, Gan PY, Kanellis J, Ngui J, Laurie K, Thursky K, Leung VK, Holdsworth SR.

Transplant Proc. 2018 Dec;50(10):3367-3370. doi: 10.1016/j.transproceed.2018.07.017.

PMID:
30577209
10.

Allocation of deceased donor kidneys: A review of international practices.

Lee D, Kanellis J, Mulley WR.

Nephrology (Carlton). 2019 Jun;24(6):591-598. doi: 10.1111/nep.13548. Epub 2019 Apr 29. Review.

PMID:
30536674
11.

Everolimus and Long-term Clinical Outcomes in Kidney Transplant Recipients: A Registry-based 10-year Follow-up of 5 Randomized Trials.

Ying T, Wong G, Lim WH, Clayton P, Kanellis J, Pilmore H, Campbell S, O'Connell PJ, Russ G, Chadban S.

Transplantation. 2019 Aug;103(8):1705-1713. doi: 10.1097/TP.0000000000002499.

PMID:
30365464
12.

Diagnostic application of kidney allograft-derived absolute cell-free DNA levels during transplant dysfunction.

Whitlam JB, Ling L, Skene A, Kanellis J, Ierino FL, Slater HR, Bruno DL, Power DA.

Am J Transplant. 2019 Apr;19(4):1037-1049. doi: 10.1111/ajt.15142. Epub 2018 Nov 9.

PMID:
30312536
13.

Establishing a Core Outcome Measure for Life Participation: A Standardized Outcomes in Nephrology-kidney Transplantation Consensus Workshop Report.

Ju A, Josephson MA, Butt Z, Jowsey-Gregoire S, Tan J, Taylor Q, Fowler K, Dobbels F, Caskey F, Jha V, Locke J, Knoll G, Ahn C, Hanson CS, Sautenet B, Manera K, Craig JC, Howell M, Rutherford C, Tong A, Harden P, Hawley C, Holdaas H, Israni A, Jesse M, Kane B, Kanellis J, Kiberd B, Kim J, Larsen C, Leichtman A, Lentine K, Malone A, Mannon R, Oberbauer R, Patzer R, Peipert JD, Phan HA, Poggio E, Reed R, Scandling J, Tang I, Watson C, Contrares D, Contreras P, Cross D, Juodvalkis E, Koide D, Koide J, Kozarewicz A, Kozarewicz L, Kozarewicz R, Koritala A, Lisiecki E, Lipuma C, Lyman M, Mueller R, Mueller G, Noble L, Nolan N, Nolan S, Thomas J, Urbancyzk L, Zerante J, Zerante S; SONG-Tx Life Participation Workshop Investigators; Health professionals (*includes 2 patients from the SONG-Tx Graft Health Expert Working Group); Patients and family members.

Transplantation. 2019 Jun;103(6):1199-1205. doi: 10.1097/TP.0000000000002476.

PMID:
30300284
14.

Factors associated with anaemia in kidney transplant recipients in the first year after transplantation: a cross-sectional study.

Lim AKH, Kansal A, Kanellis J.

BMC Nephrol. 2018 Oct 5;19(1):252. doi: 10.1186/s12882-018-1054-7.

15.

Kidney donation and transplantation in Australia: more than a supply and demand equation.

Chapman JR, Kanellis J.

Med J Aust. 2018 Sep 17;209(6):242-243. No abstract available.

PMID:
30208813
16.

Access to waitlisting for deceased donor kidney transplantation in Australia.

Sypek MP, Clayton PA, Lim W, Hughes P, Kanellis J, Wright J, Chapman J, McDonald SP.

Nephrology (Carlton). 2019 Jul;24(7):758-766. doi: 10.1111/nep.13484. Epub 2019 Apr 25.

PMID:
30159950
17.

Identifying Outcomes that Are Important to Living Kidney Donors: A Nominal Group Technique Study.

Hanson CS, Chapman JR, Gill JS, Kanellis J, Wong G, Craig JC, Teixeira-Pinto A, Chadban SJ, Garg AX, Ralph AF, Pinter J, Lewis JR, Tong A.

Clin J Am Soc Nephrol. 2018 Jun 7;13(6):916-926. doi: 10.2215/CJN.13441217. Epub 2018 May 31.

18.

De novo or early conversion to everolimus and long-term cancer outcomes in kidney transplant recipients: A trial-based linkage study.

Ying T, Wong G, Lim W, Kanellis J, Pilmore H, Campbell S, Masterson R, Walker R, O'Connell P, Russ G, Chadban S.

Am J Transplant. 2018 Dec;18(12):2977-2986. doi: 10.1111/ajt.14948. Epub 2018 Jun 27.

19.

Natural killer cell function predicts severe infection in kidney transplant recipients.

Dendle C, Gan PY, Polkinghorne KR, Ngui J, Stuart RL, Kanellis J, Thursky K, Mulley WR, Holdsworth S.

Am J Transplant. 2019 Jan;19(1):166-177. doi: 10.1111/ajt.14900. Epub 2018 Jun 13.

20.

Occupational Legionella pneumophila Exposure in a Street Sweeper with a Renal Transplant.

Tedjaseputra A, Manzoor M, Dendle C, Kanellis J.

Nephrology (Carlton). 2018 May;23(5):493-494. doi: 10.1111/nep.13092. No abstract available.

PMID:
29696762
21.

Confirmed microsporidial graft infection in a HIV-negative renal transplant recipient: A case report and review of the literature.

Brown M, Longano A, Dendle C, Polkinghorne KR, Kanellis J.

Transpl Infect Dis. 2018 Jun;20(3):e12888. doi: 10.1111/tid.12888. Epub 2018 Apr 10. Review.

PMID:
29570921
22.

Seroresponses and safety of 13-valent pneumococcal conjugate vaccination in kidney transplant recipients.

Dendle C, Stuart RL, Polkinghorne KR, Balloch A, Kanellis J, Ling J, Kummrow M, Moore C, Thursky K, Buttery J, Mulholland K, Gan PY, Holdsworth S, Mulley WR.

Transpl Infect Dis. 2018 Apr;20(2):e12866. doi: 10.1111/tid.12866. Epub 2018 Apr 1.

PMID:
29512234
23.

Survival and Quality of Life Impact of a Risk-based Allocation Algorithm for Deceased Donor Kidney Transplantation.

Calisa V, Craig JC, Howard K, Howell M, Alexander S, Chadban SJ, Clayton P, Lim WH, Kanellis J, Wyburn K, Johnson DW, McDonald SP, Opdam H, Chapman JR, Yang J, Wong G.

Transplantation. 2018 Sep;102(9):1530-1537. doi: 10.1097/TP.0000000000002144.

PMID:
29485512
24.

Clinicians' attitudes and approaches to evaluating the potential living kidney donor-recipient relationship: An interview study.

Ralph AF, Butow P, Craig JC, Chapman JR, Gill JS, Kanellis J, Tong A.

Nephrology (Carlton). 2019 Feb;24(2):252-262. doi: 10.1111/nep.13238.

PMID:
29437270
25.

Direct and indirect costs incurred by Australian living kidney donors.

Barnieh L, Kanellis J, McDonald S, Arnold J, Sontrop JM, Cuerden M, Klarenbach S, Garg AX, Boudville N; Donor Nephrectomy Outcomes Research (DONOR) Network.

Nephrology (Carlton). 2018 Dec;23(12):1145-1151. doi: 10.1111/nep.13205.

PMID:
29215180
26.

The Lived Experience of "Being Evaluated" for Organ Donation: Focus Groups with Living Kidney Donors.

Hanson CS, Ralph AF, Manera KE, Gill JS, Kanellis J, Wong G, Craig JC, Chapman JR, Tong A.

Clin J Am Soc Nephrol. 2017 Nov 7;12(11):1852-1861. doi: 10.2215/CJN.03550417. Epub 2017 Oct 9.

27.

Untapped potential in Australian hospitals for organ donation after circulatory death.

Rakhra SS, Opdam HI, Gladkis L, Arcia B, Fink MA, Kanellis J, Macdonald PS, Snell GI, Pilcher DV.

Med J Aust. 2017 Sep 2;207(7):294-301.

PMID:
28954604
28.

A Model of Acute Antibody-Mediated Renal Allograft Rejection in the Sensitized Rata.

Chandran SR, Mulley WR, Kanellis J, Nikolic-Paterson DJ, Ma FY.

Exp Clin Transplant. 2018 Jun;16(3):294-300. doi: 10.6002/ect.2016.0316. Epub 2017 Jul 31.

29.

Developing Consensus-Based Priority Outcome Domains for Trials in Kidney Transplantation: A Multinational Delphi Survey With Patients, Caregivers, and Health Professionals.

Sautenet B, Tong A, Manera KE, Chapman JR, Warrens AN, Rosenbloom D, Wong G, Gill J, Budde K, Rostaing L, Marson L, Josephson MA, Reese PP, Pruett TL, Hanson CS, O'Donoghue D, Tam-Tham H, Halimi JM, Shen JI, Kanellis J, Scandling JD, Howard K, Howell M, Cross N, Evangelidis N, Masson P, Oberbauer R, Fung S, Jesudason S, Knight S, Mandayam S, McDonald SP, Chadban S, Rajan T, Craig JC.

Transplantation. 2017 Aug;101(8):1875-1886. doi: 10.1097/TP.0000000000001776.

30.

Long-term graft survival in patients with chronic antibody-mediated rejection with persistent peritubular capillaritis treated with intravenous immunoglobulin and rituximab.

Mulley WR, Huang LL, Ramessur Chandran S, Longano A, Amos LAR, Polkinghorne KR, Nikolic-Paterson DJ, Kanellis J.

Clin Transplant. 2017 Sep;31(9). doi: 10.1111/ctr.13037. Epub 2017 Jul 13.

PMID:
28640458
31.

Inhibition of Spleen Tyrosine Kinase Reduces Renal Allograft Injury in a Rat Model of Acute Antibody-Mediated Rejection in Sensitized Recipients.

Ramessur Chandran S, Han Y, Tesch GH, Di Paolo J, Mulley WR, Kanellis J, Ma FY, Nikolic-Paterson DJ.

Transplantation. 2017 Aug;101(8):e240-e248. doi: 10.1097/TP.0000000000001826.

PMID:
28594748
32.

Expectations and Experiences of Follow-up and Self-Care After Living Kidney Donation: A Focus Group Study.

Manera KE, Hanson CS, Chapman JR, Kanellis J, Gill J, Craig JC, Chadban SJ, Wong G, Ralph AF, Tong A.

Transplantation. 2017 Oct;101(10):2627-2635. doi: 10.1097/TP.0000000000001771.

PMID:
28538499
33.

Epstein-Barr virus encephalitis in solid organ transplantation.

Lau JSY, Low ZM, Abbott I, Shochet L, Kanellis J, Kitching AR, Korman TM.

New Microbiol. 2017 Jul;40(3):212-217. Epub 2017 May 17. Review.

34.

Cardiovascular Parameters to 2 years After Kidney Transplantation Following Early Switch to Everolimus Without Calcineurin Inhibitor Therapy: An Analysis of the Randomized ELEVATE Study.

Holdaas H, de Fijter JW, Cruzado JM, Massari P, Nashan B, Kanellis J, Witzke O, Gutierrez-Dalmau A, Turkmen A, Wang Z, Lopez P, Bernhardt P, Kochuparampil J, van der Giet M, Murbraech K; ELEVATE Study Group.

Transplantation. 2017 Oct;101(10):2612-2620. doi: 10.1097/TP.0000000000001739.

PMID:
28333860
35.

Skin cancer history, sun-related attitudes, behaviour and sunburn among renal transplant recipients versus general population.

Leung VKY, Dobbinson SJ, Goodman DJ, Kanellis J, Chong AH.

Australas J Dermatol. 2018 May;59(2):e106-e113. doi: 10.1111/ajd.12591. Epub 2017 Mar 23.

PMID:
28332195
36.

De novo thrombotic microangiopathy following simultaneous pancreas and kidney transplantation managed with eculizumab.

Shochet L, Kanellis J, Simpson I, Ta J, Mulley W.

Nephrology (Carlton). 2017 Feb;22 Suppl 1:23-27. doi: 10.1111/nep.12936. Review.

PMID:
28176480
37.

The risk of cancer in kidney transplant recipients may be reduced in those maintained on everolimus and reduced cyclosporine.

Lim WH, Russ GR, Wong G, Pilmore H, Kanellis J, Chadban SJ.

Kidney Int. 2017 Apr;91(4):954-963. doi: 10.1016/j.kint.2016.11.008. Epub 2017 Jan 18.

PMID:
28109543
38.

Donor and Recipient Views on Their Relationship in Living Kidney Donation: Thematic Synthesis of Qualitative Studies.

Ralph AF, Butow P, Hanson CS, Chadban SJ, Chapman JR, Craig JC, Kanellis J, Luxton G, Tong A.

Am J Kidney Dis. 2017 May;69(5):602-616. doi: 10.1053/j.ajkd.2016.09.017. Epub 2016 Nov 23. Review.

PMID:
27889296
39.

Spleen Tyrosine Kinase Signaling Promotes Myeloid Cell Recruitment and Kidney Damage after Renal Ischemia/Reperfusion Injury.

Ryan J, Kanellis J, Blease K, Ma FY, Nikolic-Paterson DJ.

Am J Pathol. 2016 Aug;186(8):2032-2042. doi: 10.1016/j.ajpath.2016.04.007. Epub 2016 Jun 17.

40.

Primary central nervous system posttransplant lymphoproliferative disease: An uncommon diagnostic dilemma.

Degen D, Kanellis J, Hughes P, Barit D, Ierino F.

Nephrology (Carlton). 2016 Jun;21(6):528. doi: 10.1111/nep.12626. No abstract available.

PMID:
27188412
41.

Long-term outcomes of end-stage kidney disease for patients with lupus nephritis.

Zhang L, Lee G, Liu X, Pascoe EM, Badve SV, Boudville NC, Clayton PA, Hawley CM, Kanellis J, McDonald SP, Peh CA, Polkinghorne KR, Johnson DW.

Kidney Int. 2016 Jun;89(6):1337-45. doi: 10.1016/j.kint.2016.02.014. Epub 2016 Apr 8.

PMID:
27165824
42.

Different faces of Nocardia infection in renal transplant recipients.

Shrestha S, Kanellis J, Korman T, Polkinghorne KR, Brown F, Yii M, Kerr PG, Mulley W.

Nephrology (Carlton). 2016 Mar;21(3):254-60. doi: 10.1111/nep.12585.

PMID:
26820918
43.

Recurrent glomerulopathy in a renal allograft due to lecithin cholesterol acyltransferase deficiency.

Liew H, Simpson I, Kanellis J, Mulley WR.

Nephrology (Carlton). 2016 Jan;21(1):73-4. doi: 10.1111/nep.12554. No abstract available.

PMID:
26693848
44.

Methods in renal research: kidney transplantation in the rat.

Tillou X, Howden BO, Kanellis J, Nikolic-Paterson DJ, Ma FY.

Nephrology (Carlton). 2016 Jun;21(6):451-6. doi: 10.1111/nep.12697. Review.

PMID:
26648592
45.

BK Virus Associated Nephropathy, a Cause of Early Renal Allograft Dysfunction: A Single Centre Study.

Shrestha S, Kerr PG, Kanellis J, Polkinghorne KR, Brown F, Yii M, Mulley W.

Kathmandu Univ Med J (KUMJ). 2015 Apr-Jun;13(50):140-5.

PMID:
26643831
46.

Renal transplant ultrasound: The nephrologist's perspective.

Leong KG, Coombs P, Kanellis J.

Australas J Ultrasound Med. 2015 Nov;18(4):134-142. doi: 10.1002/j.2205-0140.2015.tb00220.x. Epub 2015 Dec 31. Review.

47.

Transplant considerations in a man with von Hippel-Lindau disease with bilateral renal cell carcinoma and a pancreatic neuroendocrine tumour.

Leong KG, Kanellis J, Mulley WR.

Nephrology (Carlton). 2015 Dec;20(12):956-7. doi: 10.1111/nep.12540. No abstract available.

PMID:
26511773
48.

Long-term outcomes of end-stage kidney disease for patients with IgA nephropathy: A multi-centre registry study.

Zhang L, Liu X, Pascoe EM, Badve SV, Boudville NC, Clayton PA, De Zoysa J, Hawley CM, Kanellis J, McDonald SP, Peh CA, Polkinghorne KR, Johnson DW.

Nephrology (Carlton). 2016 May;21(5):387-96. doi: 10.1111/nep.12629.

PMID:
26393772
49.

Myeloid cell-mediated renal injury in rapidly progressive glomerulonephritis depends upon spleen tyrosine kinase.

Ryan J, Ma FY, Han Y, Ozols E, Kanellis J, Tesch GH, Nikolic-Paterson DJ.

J Pathol. 2016 Jan;238(1):10-20. doi: 10.1002/path.4598. Epub 2015 Sep 22.

PMID:
26251216
50.

International travel in the immunocompromised patient: a cross-sectional survey of travel advice in 254 consecutive patients.

Bialy C, Horne K, Dendle C, Kanellis J, Littlejohn G, Ratnam I, Woolley I.

Intern Med J. 2015 Jun;45(6):618-23. doi: 10.1111/imj.12753.

PMID:
25827660

Supplemental Content

Loading ...
Support Center